FOR INVESTORS

Are you a current SynDaver investor? Please use the form below to confirm your mailing address for annual reports!

SynDaver is a mission-driven company from top to bottom. Our customers come first, our employees second and our investors third. Some people might find it odd that we would point this out on an investor page. However, because of this approach our products are by far the most innovative in the industry, our employees love working here and our sales are growing at a phenomenal rate. THIS is how you build shareholder value and sustainable growth at the same time.

Background

SynDaver is famous for designing and building synthetic humans. These are made from water, salts and fibers and include all muscles, bones, organs, veins, arteries and other structures found in normal anatomy. The patented library of materials from which they are made mimic living tissues and are used across a wide range of industries, from medical device testing and surgical training, to secondary and college education, as well as consumer product development and crash testing.

Our Customers

Our customer base is broad, diverse, and global. We sell to every Fortune 500 medical device manufacturer, the best hospitals and medical schools in the world and educational institutions with EMT, nursing, anatomy, veterinary medicine, dentistry, engineering, mortuary science, surgical technician, physical therapy and sports science programs. We even sell to middle-school and high-school STEM education and biology programs.

Our industrial customers include the global technology elite: firms such as Apple, Facebook, Ford, General Electric, Google, Lear, Microsoft, Nike, Procter and Gamble, Underwriters Laboratories (UL) and many others.

Our government customers include the U.S. Food and Drug Administration, the U.S. Consumer Product Safety Commission, the U.S. State Department, the Health Services of Canada and the UK and every branch of the U.S. military. We also sell to NATO and friendly governments worldwide.

Our media customers include ABC, AMC, CBS, NBC, PBS and The Discovery Channel. Our products have been seen on too many news programs to list, as well as “Shark Tank” (ABC and CNBC), “Grey’s Anatomy” (ABC), “CSI” (CBS), “Inside Edition” (ABC), “Mythbusters” (Discovery), “Mythbusters 2.0” (Science Channel), “Crossbones” (NBC), “Shipping Wars” (AMC) and “Quest” (PBS).

Research and Development

SynDaver is constantly refining technologies, seeking new markets for existing products and designing new products for emerging applications. We created the SynDaver Synthetic Human (SSH) product line in 2011 with our torso model and followed with our first generation full body in 2012. In 2013 we started designing a line of partial task trainers for nursing and EMS education. In 2017 we launched the SynDaver Surgical Canine for the veterinary medical education community, in 2018 we followed with the SynDaver Advanced Modular Mannequin (SAMM), in 2019 we launched CopyCat and SynFrog for high school dissection and in 2020 we even began working on 3D printers! Several additional product announcements are coming later this year.

There are currently 18 issued U.S. Patents on our body of work.

Historical Performance

SynDaver has been in business for nearly 20 years. Over the most recent decade our average annual revenue growth has been more than 30% and in 2022 we are projecting YOY annual growth of 75%. To continue building on our success we are expanding our sales teams across multiple divisions, adding distributors worldwide, increasing marketing efforts and tapping into new verticals with new products.

Corporate Governance

Dr. Christopher Sakezles is our Founder, CEO, Chief Technology Officer and Chairman of the Board of Directors for the SynDaver group of companies. He is expected to remain in all of these positions indefinitely and controls a supermajority of company shares.

Investor Relations

SynDaver offers shares periodically via private offering. On such occasions we verify identity and require a nondisclosure agreement before a prospectus is released. Minimum investment level varies.

We do not currently issue quarterly reports but do send out annual updates to shareholders via physical mail. If you are a current investor and your address has changed please use the form below to have your address updated in our system.

You may also use the form below to be added to our investor waiting list.

    Check ALL That Apply:*

    Primary Interests:*

    synjoshFor Investors